Deubiquitinating c-Myc: USP36 steps up in the nucleolus

Cell Cycle

Volumn 14, Issue 24, 2015, Pages 3786-3793

  Sun, Xiao Xin ^a   Sears, Rosalie C ^a   Dai, Mu Shui ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

C Myc; Deubiquitinating enzymes; Nucleolus; Ubiquitination; USP36

Indexed keywords

ATROGIN 1; BETA TRCP PROTEIN; CARBOXYL TERMINUS OF HSC70 INTERACTING PROTEIN; DEUBIQUITINASE; FBXO28 PROTEIN; HUWE1 PROTEIN; MYC PROTEIN; PIRH2 PROTEIN; S PHASE KINASE ASSOCIATED PROTEIN 2; TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL SUBFAMILY C MEMBER 4 ASSOCIATED PROTEIN; TRIM32 PROTEIN; UNCLASSIFIED DRUG; USP28 PROTEIN; DEUBIQUITINASE USP37, HUMAN; PROTEINASE; UBIQUITIN THIOLESTERASE; USP28 PROTEIN, HUMAN; USP36 PROTEIN, HUMAN;

ARTICLE; CELL CYCLE PROGRESSION; CELL GROWTH; CELL PROLIFERATION; HUMAN; NONHUMAN; NUCLEOLUS; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN STABILITY; TRANSACTIVATION; UBIQUITINATION; ANIMAL; METABOLISM; PHYSIOLOGY;

ANIMALS; CELL NUCLEOLUS; ENDOPEPTIDASES; HUMANS; PROTO-ONCOGENE PROTEINS C-MYC; UBIQUITIN THIOLESTERASE; UBIQUITINATION;

EID: 84964057646     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.1080/15384101.2015.1093713     Document Type: Article

References (71)

1. Lin CY, Loven J, Rahl PB, Paranal RM, Burge CB, Bradner JE, Lee TI, Young RA. Transcriptional amplification in tumor cells with elevated c-Myc. Cell 2012; 151:56-67; PMID:23021215; http://dx.doi.org/10.1016/j.cell.2012.08.026
2. Nie Z, Hu G, Wei G, Cui K, Yamane A, Resch W, Wang R, Green DR, Tessarollo L, Casellas R, et al. c-Myc is a universal amplifier of expressed genes in lym­phocytes and embryonic stem cells. Cell 2012; 151:68-79; PMID:23021216; http://dx.doi.org/10.1016/j-cell.2012.08.033
3. Sabo A, Kress TR, Pelizzola M, de Pretis S, Gorski MM, Tesi A, Morelli MJ, Bora P, Doni M, Verrecchia A, et al. Selective transcriptional regulation by Myc in cellular growth control and lymphomagenesis. Nature 2014; 511: 488-492; PMID:25043028; http://dx.doi.org/10.1038/nature13537
4. Walz S, Lorenzin F, Morton J, Wiese KE, von Eyss B, Herold S, Rycak L, Dumay-Odelot H, Karim S, Bartkuhn M, et al. Activation and repression by onco-genic MYC shape tumour-specific gene expression profiles. Nature 2014; 511:483-487; PMID:25043018; http://dx.doi.org/10.1038/nature13473
5. Adhikary S, Eilers M. Transcriptional regulation and transformation by Myc proteins. Nat Rev Mol Cell Biol 2005; 6:635-645; PMID:16064138; http://dx.doi.org/doi:10.1038/nrm1703
6. Meyer N, Penn LZ. Reflecting on 25 years with MYC. Nat Rev Cancer 2008; 8:976-990; PMID:19029958; http://dx.doi.org/10.1038/nrc2231
7. van Riggelen J, Yetil A, Felsher DW. MYC as a regulator of ribosome biogenesis and protein synthesis. Nat Rev Cancer 2010; 10: 301-309; PMID:19029958; http://dx.doi.org/10.1038/nrc2231
8. Nesbit CE, Tersak JM, aProchownik EV. MYC onco-genes and human neoplastic disease. Oncogene 1999; 18:3004-3016; PMID:20332779; http://dx.doi.org/10.1038/nrc2819
9. Farrell AS, Sears RC. MYC degradation. Cold Spring Harb Perspect Med 2014; 4: p2: a014365; PMID:24591536; http://dx.doi.org/10.1101/cshperspect.a014365
10. Hann SR. Role of post-translational modifications in regulating c-Myc proteolysis, transcriptional activity and biological function. Semin Cancer Biol 2006; 16:288-302; PMID:16938463; http://dx.doi.org/10.1016/j.semcancer.2006.08.004; PMID:16938463
11. Sears R, Leone G, DeGregori J, Nevins JR. Ras enhances Myc protein stability. Mol Cell 1999; 3:169-179; PMID:10078200; http://dx.doi.org/10.1016/S1097-2765(00)80308-1
12. Sears R, Nuckolls F, Haura E, Taya Y, Tamai K, Nevins JR. Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. Genes Dev 2000;14:2501-2514; PMID:11018017; http://dx.doi.org/10.1101/gad.836800
13. Sears RC. The life cycle of C-myc: from synthesis to degradation. Cell cycle 2004; 3:1133-1137; PMID:15467447; http://dx.doi.org/10.4161/cc.3.9.1145
14. Conacci-Sorrell M, McFerrin L, Eisenman, RN. An overview of MYC and its interactome. Cold Spring Harb Perspect Med 2014; 4, a014357; PMID:24384812; http://dx.doi.org/10.1101/cshperspect.a014357
15. Tu WB, Helander S, Pilstal R, Hickman KA, Lourenco C, Jurisica I, Raught B, Wallner B, Sunnerhagen M, Penn LZ. Myc and its interactors take shape. Biochim Biophys Acta 2015; 1849:469-483; PMID:24933113; http://dx.doi.org/10.1016/j.bbagrm.2014.06.002
16. Ciechanover A, DiGiuseppe JA, Bercovich B, Orian A, Richter JD, Schwartz AL, Brodeur GM. Degradation of nuclear oncoproteins by the ubiquitin system in vitro. Proc Natl Acad Sci U S A 1991; 88:139-143; PMID:1846034
17. Flinn EM, Busch CM, Wright AP. myc boxes, which are conserved in myc family proteins, are signals for protein degradation via the proteasome. Mol Cell Biol 1998; 18:5961-5969; PMID:9742113
18. Lutterbach B, Hann SR. Hierarchical phosphorylation at N-terminal transformation-sensitive sites in c-Myc protein is regulated by mitogens and in mitosis. Mol Cell Biol 1994; 14:5510-5522; PMID:8035827; http://dx.doi.org/10.1128/MCB.14.8.5510
19. Gregory MA, Qi Y, Hann SR. Phosphorylation by gly-cogen synthase kinase-3 controls c-myc proteolysis and subnuclear localization. J Biol Chem 2003; 278:51606-51612; PMID:14563837; http://dx.doi.org/10.1074/jbc.M310722200
20. Chang DW, Claassen GF, Hann SR, Cole MD. The c-Myc transactivation domain is a direct modulator of apoptotic versus proliferative signals. Mol Cell Biol 2000; 20:4309-4319; PMID:10825194; http://dx.doi.org/10.1128/MCB.20.12.4309-4319.2000
21. Lutterbach B, aHann SR. Hierarchical phosphorylation at N-terminal transformation-sensitive sites in c-Myc protein is regulated by mitogens and in mitosis. Mol Cell Biol 1994; 14:5510-5522; PMID:8035827; http://dx.doi.org/10.1128/MCB.14.8.5510
22. Oster SK, Ho CS, Soucie EL, Penn LZ. The myc onco-gene: MarvelouslY Complex. Adv Cancer Res 2002; 84:81-154; PMID:11885563; http://dx.doi.org/10.1016/S0065-230X(02)84004-0
23. Yeh E, Cunningham M, Arnold H, Chasse D, Mon-teith T, Ivaldi G, Hahn WC, Stukenberg PT, Shenoli-kar S, Uchida T, et al. A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells. Nat Cell Biol 2004; 6:308-318; PMID:15048125; http://dx.doi.org/10.1038/ncb1110
24. Moberg KH, Mukherjee A, Veraksa A, Artavanis-Tsa-konas S, Hariharan IK. The Drosophila F box protein archipelago regulates dMyc protein levels in vivo. Curr Biol 2004; 14:965-974; PMID:15182669; http://dx.doi.org/10.1016/j.cub.2004.04.040
25. Yada M, Hatakeyama S, Kamura T, Nishiyama M, Tsunematsu R, Imaki H, Ishida N, Okumura F, Nakayama K, Nakayama KI. Phosphorylation-depen-dent degradation of c-Myc is mediated by the F-box protein Fbw7. EMBO J 2004; 23:2116-2125; PMID:15103331; http://dx.doi.org/10.1038/sj.emboj.7600217
26. Welcker M, Orian A, Jin J, Grim JE, Harper JW, Eisenman RN, Clurman B E. The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation. Proc Natl Acad Sci U S A 2004; 101:9085-9090; PMID:15150404; http://dx.doi.org/10.1073/pnas.0402770101
27. Welcker M, Orian A, Grim JE, Eisenman RN, Clur-man BE. A nucleolar isoform of the Fbw7 ubiquitin ligase regulates c-Myc and cell size. Curr Biol 2004; 14:965-974; PMID:15498494; http://dx.doi.org/10.1016/j.cub.2004.09.083
28. Bahram F, von der Lehr N, Cetinkaya C, Larsson LG. c-Myc hot spot mutations in lymphomas result in inefficient ubiquitination and decreased proteasome-mediated turnover. Blood 2000; 95:2104-2110; PMID:10706881
29. Gregory MA, Hann SR. c-Myc proteolysis by the ubiq-uitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells. Mol Cell Biol. 2000; 20:2423-2435; PMID:10713166; http://dx.doi.org/10.1128/MCB.20.7.2423-2435.2000
30. Salghetti SE, Kim SY, Tansey WP. Destruction ofMyc by ubiquitin-mediated proteolysis: cancer-associated and transforming mutations stabilize Myc. EMBO J 1999; 18, 717-726; PMID:9927431
31. Hemann MT, Bric A, Teruya-Feldstein J, Herbst A, Nilsson JA, Cordon-Cardo C, Cleveland JL, Tansey WP, Lowe SW. Evasion ofthe p53 tumour surveillance network by tumour-derived MYC mutants. Nature 2005; 436:807-811; PMID:16094360; http://dx.doi.org/10.1038/nature03845
32. Wang X, Cunningham M, Zhang X, Tokarz S, Laraway B, Troxell M, Sears RC. Phosphorylation regulates c-Myc's oncogenic activity in the mammary gland. Cancer Res 2011; 71:925-936; PMID:21266350; http://dx.doi.org/10.1158/0008-5472.CAN-10-1032
33. Welcker M, Clurman BE. FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nat Rev Cancer 2008; 8:83-93; PMID:18094723; http://dx.doi.org/10.1038/nrc2290
34. von der Lehr N, Johansson S, Wu S, Bahram F, Castell A, Cetinkaya C, Hydbring P, Weidung I, Nakayama K, Nakayama KI, et al. The F-box protein Skp2 participates in c-Myc proteosomal degradation and acts as a cofactor for c-Myc-regulated transcription. Mol Cell 2003; 11:1189-1200; PMID:12769844; http://dx.doi.org/10.1016/S1097-2765(03)00193-X
35. von der Lehr N, Johansson S, Larsson LG. Implication of the ubiquitin/proteasome system in Myc-regulated transcription. Cell Cycle 2003; 2:403-407; PMID:12963825; http://dx.doi.org/10.4161/cc.2.5.484
36. Kim SY, Herbst A, Tworkowski KA, Salghetti SE, Tan-sey WP. Skp2 regulates Myc protein stability and activity. Mol Cell 2003; 11:1177-1188; PMID:12769843; http://dx.doi.org/10.1016/S1097-2765(03)00173-4
37. Zhang Q, Spears E, Boone DN, Li Z, Gregory MA, Hann SR. Domain-specific c-Myc ubiquitylation controls c-Myc transcriptional and apoptotic activity. Proc Natl Acad Sci U S A 2013; 110:978-983; PMID:23277542; http://dx.doi.org/10.1073/pnas.1208334110
38. Farrell AS, Pelz C, Wang X, Daniel CJ, Wang Z, Su Y, Janghorban M, Zhang X, Morgan C, Impey S, et al. Pin1 regulates the dynamics of c-Myc DNA binding to facilitate target gene regulation and oncogenesis. Mol Cell Biol 2013; 33:2930-2949; PMID:23716601; http://dx.doi.org/10.1128/MCB.01455-12
39. Chan CH, Lee SW, Li CF, Wang J, Yang WL, Wu CY, Wu J, Nakayama KI, Kang HY, Huang HY, et al. Deciphering the transcriptional complex critical for RhoA gene expression and cancer metastasis. Nat Cell Biol 2010;12:457-467; PMID:20383141; http://dx.doi.org/10.1038/ncb2047
40. Li X, Bian Y, Takizawa Y, Hashimoto T, Ikoma T, Tanaka J, Kitamura N, Inagaki Y, Komada M, Tanaka T. ERK-dependent downregulation of Skp2 reduces Myc activity with HGF, leading to inhibition of cell proliferation through a decrease in Id1 expression. Mol Cancer Res 2013; 11:1437-1447; PMID:24177224; http://dx.doi.org/10.1158/1541-7786.MCR-12-0718
41. Adhikary S, Marinoni F, Hock A, Hulleman E, Popov N, Beier R, Bernard S, Quarto M, Capra M, Goettig S, et al. The ubiquitin ligase HectH9 regulates transcrip-tional activation by Myc and is essential for tumor cell proliferation. Cell 2005; 123:409-421; PMID:16269333; http://dx.doi.org/10.1016/j.cell.2005.08.016
42. Peter S, Bultinck J, Myant K, Jaenicke LA, Walz S, Muller J, Gmachl M, Treu M, Boehmelt G, Ade CP, et al. Tumor cell-specific inhibition of MYC function using small molecule inhibitors ofthe HUWE1 ubiquitin ligase. EMBO Mol Med 2014; 6:1525-1541; PMID:25253726; http://dx.doi.org/10.15252/emmm.201403927
43. Cepeda D, Ng HF, Sharifi HR Mahmoudi S, Cerrato VS, Fredlund E, Magnusson K, Nilsson H, Malyukova A, Rantala J, et al. CDK-mediated activation of the SCF(FBXO) (28) ubiquitin ligase promotes MYC-driven transcription and tumourigenesis and predicts poor survival in breast cancer. EMBO Mol Med 2013; 5:999-1018; PMID:23776131; http://dx.doi.org/10.1002/emmm.201202341
44. Popov N, Schulein C, Jaenicke LA, Eilers M. Ubiquity-lation of the amino terminus of Myc by SCF(fl-TrCP) antagonizes SCF(Fbw7)-mediated turnover. Nat Cell Biol 2010; 12:973-981; PMID:20852628; http://dx.doi.org/10.1038/ncb2104
45. Yi YW, Kang HJ, Bae EJ, Oh S, Seong YS, Bae I. b-TrCP1 degradation is a novel action mechanism of PI3K/mTOR inhibitors in triple-negative breast cancer cells. Exp Mol Med 2015; 47, e143; PMID:25721419; http://dx.doi.org/10.1038/emm.2014.127
46. Choi SH, Wright JB, Gerber SA, Cole MD. Myc protein is stabilized by suppression of a novel E3 ligase complex in cancer cells. Genes Dev 2010; 24:1236-1241; PMID:20551172; http://dx.doi.org/10.1101/gad.1920310
47. Jamal A, Swarnalatha M, Sultana S, Joshi P, Panda SK, Kumar V. The G1 phase E3 ubiquitin ligase TRUSS that gets deregulated in human cancers is a novel substrate of the S-phase E3 ubiquitin ligase Skp2. Cell Cycle, 2015; 14:2688-2700; PMID:26038816; http://dx.doi.org/10.1080/15384101.2015.1056946
48. Schwamborn JC, Berezikov E, Knoblich JA. The TRIM-NHL protein TRIM32 activates micro RNAs and prevents self-renewal in mouse neural progenitors. Cell 2009; 136:913-925; PMID:19269368; http://dx.doi.org/10.1016/j.cell.2008.12.024
49. Hakem A, Bohgaki M, Lemmers B, Tai E, Salmena L, Matysiak-Zablocki E, Jung YS, Karaskova J, Kaustov L, Duan S, et al. Role ofPirh2 in mediating the regulation of p53 and c-Myc. PLoS genetics 2011; 7:e1002360; PMID:22125490; http://dx.doi.org/10.1371/journal.pgen.1002360
50. Ballinger CA, Connell P, Wu Y, Hu Z, Thompson LJ, Yin LY, Patterson C. Identification of CHIP, a novel tetratricopeptide repeat-containing protein that inter­acts with heat shock proteins and negatively regulates chaperone functions. Mol Cell Biol 1999; 19:4535-4545; PMID:10330192
51. Paul I, Ahmed SF, Bhowmik A, Deb S, Ghosh MK. The ubiquitin ligase CHIP regulates c-Myc stability and transcriptional activity. Oncogene 2013; 32:1284-1295; PMID:22543587; http://dx.doi.org/10.1038/onc.2012.144
52. Mei Z, Zhang D, Hu B, Wang J, Shen X, a Xiao W. FBXO32 Targets c-Myc for Proteasomal Degradation and Inhibits c-Myc Activity. J Biol Chem 2015; 290:16202-16214; PMID:25944903; http://dx.doi.org/10.1074/jbc.M115.645978
53. Komander D, Clague MJ, Urbe S. Breaking the chains: structure and function of the deubiquitinases. Nat Rev Mol Cell Biol 2009; 10:550-563; PMID:19626045; http://dx.doi.org/10.1038/nrm2731
54. Nijman SM, Luna-Vargas MP, Velds A, Brummelkamp TR, Dirac AM, Sixma TK, Bernards R. A genomic and functional inventory of deubiquitinating enzymes. Cell 2005; 123:773-786; PMID:16325574; http://dx.doi.org/10.1016/j.cell.2005.11.007
55. Popov N, Wanzel M, Madiredjo M, Zhang D, Beijers-bergen R, Bernards R, Moll R, Elledge SJ, Eilers M. The ubiquitin-specific protease USP28 is required for MYC stability. Nat Cell Biol 2007; 9:765-774; PMID:17558397; http://dx.doi.org/10.1038/ncb1601
56. Popov N, Herold S, Llamazares M, Schulein C, Eilers M. Fbw7 and Usp28 regulate myc protein stability in response to DNA damage. Cell cycle 2007; 6:2327-2331; PMID:17873522; http://dx.doi.org/10.1016/j.celrep.2014.09.057
57. Schulein-Volk C, Wolf E, Zhu J, Xu W, Taranets L, Hellmann A, Janicke LA, Diefenbacher ME, Behrens A, Eilers M, et al. Dual regulation of Fbw7 function and oncogenic transformation by Usp28. Cell Rep 2014; 9:1099-1109; PMID:25437563; http://dx.doi.org/10.1016/j.celrep.2014.09.057
58. Diefenbacher ME, Chakraborty A, Blake SM, Mitter R, Popov N, Eilers M, Behrens A. Usp28 counteracts Fbw7 in intestinal homeostasis and cancer. Cancer Res 2015; 75:1181-1186; PMID:25716680; http://dx.doi.org/10.1158/0008-5472.CAN-14-1726
59. Pan J, Deng Q, Jiang C, Wang X, Niu T, Li H, Chen T, Jin J, Pan W, Cai X, et al. USP37 directly deubiqui-tinates and stabilizes c-Myc in lung cancer. Oncogene 2015; 34:3957-3967; PMID:25284584; http://dx.doi.org/10.1038/onc.2014.327
60. Arabi A, Wu S, Ridderstrale K, Bierhoff H, Shiue C, Fatyol K, Fahlen S, Hydbring P, Soderberg O, Grummt I, et al. c-Myc associates with ribosomal DNA and activates RNA polymerase I transcription. Nat Cell Biol 2005; 7:303-310; PMID:15723053; http://dx.doi.org/10.1038/ncb1225
61. Grandori C, Gomez-Roman N, Felton-Edkins ZA, Ngouenet C, Galloway DA, Eisenman RN, White RJ. c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I. Nat Cell Biol 2005; 7:311-318; PMID:15723054; http://dx.doi.org/10.1038/ncb1224
62. Dai MS, Lu H. Crosstalk between c-Myc and ribosome in ribosomal biogenesis and cancer. J Cell Biochem 2008; 105:670-677; PMID:18773413; http://dx.doi.org/10.1002/jcb.21895
63. van Riggelen J, Yetil A, Felsher DW. MYC as a regulator of ribosome biogenesis and protein synthesis. Nat Rev Cancer 2010; 10:301-309; PMID:20332779; http://dx.doi.org/10.1038/nrc2819
64. Sun XX, He X, Yin L, Komada M, Sears RC, Dai MS. The nucleolar ubiquitin-specific protease USP36 deubi-quitinates and stabilizes c-Myc. Proc Natl Acad Sci U S A 2015; 112:3734-3739; PMID:25775507; http://dx.doi.org/10.1073/pnas.1411713112
65. Li J, Olson LM, Zhang Z, Li L, Bidder M, Nguyen L, Pfeifer J, Rader JS. Differential display identifies overex-pression of the USP36 gene, encoding a deubiquitinat-ing enzyme, in ovarian cancer. Int J Med Sci 2008; 5:133-142; PMID:18566677; http://dx.doi.org/10.7150/ijms.5.133
66. Endo A, Kitamura N, Komada M. Nucleophosmin/ B23 regulates ubiquitin dynamics in nucleoli by recruiting deubiquitylating enzyme USP36. J Biol Chem 2009; 284:27918-27923; PMID:19679658; http://dx.doi.org/10.1074/jbc.M109.037218
67. Endo A, Matsumoto M, Inada T, Yamamoto A, Nakayama KI, Kitamura N, Komada M. Nucleolar structure and function are regulated by the deubiquitylating enzyme USP36. J Cell Sci 2009; 122:678-686; PMID:19208757; http://dx.doi.org/10.1242/jcs.044461
68. Richardson LA, Reed BJ, Charette JM, Freed EF, Fre-drickson EK, Locke MN, Baserga SJ, Gardner RG. A conserved deubiquitinating enzyme controls cell growth by regulating RNA polymerase I stability. Cell Rep 2012; 2:372-385; PMID:22902402; http://dx.doi.org/10.1016/j.celrep.2012.07.009
69. Taillebourg E, Gregoire I, Viargues P, Jacomin AC, Thevenon D, Faure M, Fauvarque MO. The deubiqui-tinating enzyme USP36 controls selective autophagy activation by ubiquitinated proteins. Autophagy 2012; 8:767-779; PMID:22622177; http://dx.doi.org/10.4161/auto.19381
70. Thevenon D, Engel E, Avet-Rochex A, Gottar M, Ber-geret E, Tricoire H, Benaud C, Baudier J, Taillebourg E, Fauvarque MO. The Drosophila ubiquitin-specific protease dUSP36/Scny targets IMD to prevent constitutive immune signaling. Cell Host Microbe 2009; 6:309-320; PMID:19837371; http://dx.doi.org/10.1016/j.chom.2009.09.007
71. Amati B, Sanchez-Arevalo Lobo VJ. MYC degradation: deubiquitinating enzymes enter the dance. Nat Cell Biol 2007; 9:729-731; PMID:17603505; http://dx.doi.org/10.1038/ncb0707-729